Antibiotic Resistance in the Bacterial Isolates of Bengaluru Lakes

Authors

  • Benita A
  • Bhasker P.A.
  • Dhanapal S.
  • Lhamu T
  • Syed Fatima Qadri St Joseph's University, Bengaluru

Keywords:

Antibiotic resistance, Antibiotics, Bengaluru lakes, Bacteria, Multi-drug Resistance.

Abstract

Increased urbanization in Bengaluru has resulted in excessive drainage of antibiotic-resistant bacteria into its pristine lakes via sewage and seepage. This pollution of the resistant bacteria is a direct result of the unregulated use and abuse of antibiotics which has only increased over the years and become a global health threat. Regarding this issue, we conducted a study to confirm the presence of antibiotic-resistant bacteria in Bengaluru lakes. For this, we sampled five representative lakes – Hebbal, Sankey Tank, Madiwala, Ulsoor, and Yediyur for bacterial isolates and cultured each on four different media. The media used were Luria Broth Agar, Tryptone (Casein Enzyme Hydrolysate), MacConkey Agar, and Blood Agar. After 24 hours of incubation, the most abundant colonies were plated in their respective media. The pure cultures were then plated with antibiotic discs belonging to five different classes (Ampicillin, Bacitracin, Erythromycin, Ciprofloxacin, and, Ceftriaxone), and the Zones of Inhibition were recorded. While all the bacterial species showed prominent Zones of Inhibition in the case of Ciprofloxacin and Ceftriaxone, many showed zones for Erythromycin, some for Bacitracin, and none for Ampicillin. We were successful in detecting antibiotic-resistant bacteria in the lakes of Bengaluru. Our results also lead us to conclude that many bacterial species indicated multi-drug resistance, with every single species indicating resistance to at least one antibiotic. With this research, we hope to raise awareness and call for more studies to be undertaken on this issue.

References

Baran, A., Kwiatkowska, A., & Potocki, L. (2023). Antibiotics and Bacterial Resistance-A Short Story of an Endless Arms Race. International Journal of Molecular Sciences, 24(6). https://doi.org/10.3390/IJMS24065777

Barreiro, C., & Barredo, J. L. (2021). Worldwide Clinical Demand for Antibiotics: Is It a Real Countdown? Methods in Molecular Biology (Clifton, N.J.), 2296, 3–15. https://doi.org/10.1007/978- 1-0716-1358-0_1

Breijyeh, Z., Jubeh, B., & Karaman, R. (2020). Resistance of Gram-Negative Bacteria to Current Antibacterial Agents and Approaches to Resolve It. Molecules, 25(6). https://doi.org/10.3390/MOLECULES25061340

Bui, T., & Preuss, C. V. (2022). Cephalosporins. NCBI.

https://www.ncbi.nlm.nih.gov/books/NBK551517/

Calhoun, C., Wermuth, H. R., & Hall, G. A. (2022). Antibiotics. StatPearls.

https://www.ncbi.nlm.nih.gov/books/NBK535443/

Day, M., Pitt, R., Mody, N., Saunders, J., Rai, R., Nori, A., Church, H., Mensforth, S., Corkin, H., Jones,

J., Naicker, P., Khan, W. M., Glover, R. T., Mortimer, K., Hylton, C., Moss, E., Pasvol, T. J., Richardson, A., Sun, S., … Fifer, H. (2022). Detection of 10 cases of ceftriaxone-resistant Neisseria gonorrhoeae in the United Kingdom, December 2021 to June 2022. Eurosurveillance, 27(46). https://doi.org/10.2807/1560-7917.ES.2022.27.46.2200803

Desjardins, M., Delgaty, K. L., Ramotar, K., Seetaram, C., & Toye, B. (2004). Prevalence and Mechanisms of Erythromycin Resistance in Group A and Group B Streptococcus: Implications for Reporting Susceptibility Results. Journal of Clinical Microbiology, 42(12), 5620. https://doi.org/10.1128/JCM.42.12.5620-5623.2004

Gould, I. M., & Bal, A. M. (2013). New antibiotic agents in the pipeline and how they can help overcome microbial resistance. Virulence, 4(2), 185–191. https://doi.org/10.4161/VIRU.22507

Habboush, Y., & Guzman, N. (2022). Antibiotic Resistance. StatPearls. https://www.ncbi.nlm.nih.gov/books/NBK513277/

Kaushik, D., Mohan, M., Borade, D. M., & Swami, O. C. (2014). Ampicillin: Rise Fall and Resurgence.

Journal of Clinical and Diagnostic Research : JCDR, 8(5), ME01. https://doi.org/10.7860/JCDR/2014/8777.4356

Kim, S., Lieberman, T. D., & Kishony, R. (2014). Alternating antibiotic treatments constrain evolutionary paths to multidrug resistance. Proceedings of the National Academy of Sciences of the United States of America, 111(40), 14494–14499. https://doi.org/10.1073/PNAS.1409800111/SUPPL_FILE/PNAS.1409800111.SD02.XLSX

Mai-Prochnow, A., Clauson, M., Hong, J., & Murphy, A. B. (2016). Gram positive and Gram negative bacteria differ in their sensitivity to cold plasma. Scientific Reports, 6. https://doi.org/10.1038/SREP38610

Nandi, A., Pecetta, S., & Bloom, D. E. (2023). Global antibiotic use during the COVID-19 pandemic: analysis of pharmaceutical sales data from 71 countries, 2020–2022. EClinicalMedicine, 57. https://doi.org/10.1016/J.ECLINM.2023.101848

Nguyen, R., Khanna, N. R., Safadi, A. O., & Sun, Y. (2022). Bacitracin Topical. StatPearls. https://www.ncbi.nlm.nih.gov/books/NBK536993/

Nikaido, H. (2009). Multidrug Resistance in Bacteria. Annual Review of Biochemistry, 78, 119. https://doi.org/10.1146/ANNUREV.BIOCHEM.78.082907.145923

Nnadozie, C. F., & Odume, O. N. (2019). Freshwater environments as reservoirs of antibiotic resistant bacteria and their role in the dissemination of antibiotic resistance genes. Environmental Pollution (Barking, Essex : 1987), 254(Pt B). https://doi.org/10.1016/J.ENVPOL.2019.113067

Pallasch, T. J. (2003). Antibiotic resistance. Dental Clinics of North America, 47(4), 623–639. https://doi.org/10.1016/S0011-8532(03)00039-9

Prevalence and Mechanisms of Erythromycin Resistance in Group A and Group B Streptococcus: Implications for Reporting Susceptibility Results - PMC. (n.d.). Retrieved May 7, 2023, from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC535282/

Read, A. F., & Woods, R. J. (2014). Antibiotic resistance management. Evolution, Medicine, and Public Health, 2014(1), 147. https://doi.org/10.1093/EMPH/EOU024

Taneja, N., & Sharma, M. (2019a). Antimicrobial resistance in the environment: The Indian scenario. The Indian Journal of Medical Research, 149(2), 119. https://doi.org/10.4103/IJMR.IJMR_331_18

Taneja, N., & Sharma, M. (2019b). Antimicrobial resistance in the environment: The Indian scenario. The Indian Journal of Medical Research, 149(2), 119. https://doi.org/10.4103/IJMR.IJMR_331_18

Tanwar, J., Das, S., Fatima, Z., & Hameed, S. (2014). Multidrug Resistance: An Emerging Crisis.

Interdisciplinary Perspectives on Infectious Diseases, 2014. https://doi.org/10.1155/2014/541340

Tarín-Pelló, A., Suay-García, B., & Pérez-Gracia, M. T. (2022). Antibiotic resistant bacteria: current situation and treatment options to accelerate the development of a new antimicrobial arsenal. Expert Review of Anti-Infective Therapy, 20(8), 1095–1108. https://doi.org/10.1080/14787210.2022.2078308

Thai, T., Salisbury, B. H., & Zito, P. M. (2023). Ciprofloxacin. StatPearls. https://www.ncbi.nlm.nih.gov/books/NBK535454/

Taneja, N., & Sharma, M. (2019). Antimicrobial resistance in the environment: The Indian scenario. The Indian Journal of Medical Research, 149(2), 119. https://doi.org/10.4103/IJMR.IJMR_331_18

Downloads

Published

2024-02-13

Issue

Vol. 13 No. 3 (2023)

Section

Research Article

License

Declaration and Copyright Transfer Form

(to be completed by authors)

I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.

  • I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
  • I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
  • I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
  •  I/We also agree to the authorship of the article in the following order:

Author’s name                                    

 

1. ________________

2. ________________

3. ________________

4. ________________

 

We  Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal.